HLA与鼻咽癌相关性研究

目的探讨HLA抗原与鼻咽癌(NPC)病因学中发病风险的关系.方法用标准微量淋巴细胞毒性试验对30例NPC患者和25例正常人进行HLA-A、B、C抗原位点检测.结果HLA-A9(RR=2.636,P=0.05)、HLA-B27(RR=3.293,P=0.048)与NPC的发病风险呈正相关,而HLA-All(RR=0.29,P=0.02),与NPC的发病风险呈负相关.结论HLA-A9、A11、B27抗原与发生鼻咽癌的发病风险有着密切的关系.     

HLA-A*3101、B*4001、B*5801、DRB1*1602等位基因与遵义地区汉族肾综合征出血热发病的相关性研究

目的 探讨HLA-A*31、B*40、B*58、DRB1*16位点基因多态性与遵义地区汉族肾综合征出血热(HFRS)的关联性.方法 采用群体研究方法,应用聚合酶链反应-序列特异性引物(PCR-SSP)技术对100例HFRS患者(患者组)和100例健康对照者(健康对照组)进行HLA-A*31、B*40、B*58、DRB1*16基因亚型分型,比较基因频率(GF),并计算其相对危险度(RR).结果 HFRS患者组HLA-A*3101、B*5801、DRB1*1602的基因频率均较对照组明显增高(RR=13.825,x2=4.296,P=0.038;RR=2.614,x2=6.133,P=0.013;RR=8.523,x2=8.865,P=0.003),差异有统计学意义(P均＜0.05);患者组HLA-B*4001的基因频率较对照组明显降低(RR=0.414,x2=6.640,P=0.010),差异有统计学意义(P＜0.05).结论 遵义地区汉族人群中,HLA-A*3101、B*5801、DRB1*1602等位基因与HFRS呈正相关,HLA-B*4001等位基因与HFRS呈负相关.     

HLA-A、B基因多态性与遵义地区汉族人群肾综合征出血热的相关性研究

目的 探讨HLA-A、B基因多态性与遵义地区汉族人群肾综合征出血热(HFRS)的关联性.方法 采用群体研究方法,应用聚合酶链反应-序列特异性引物(PCR-SSP)技术对100例肾综合征出血热患者和100例健康对照者进行HLA-A、B基因分型,比较其等位基因频率(GF),并计算其相对危险度(RR).结果 肾综合征出血热患者组中,HLA-A*31、B*58的等位基因的基因频率分别为4%、l2.5%,较健康对照组的0、5%明显增高,两组比较差异具有统计学意义(X2值分别为6.380和7.792,P<0.05,RR值分别为18.47、2.91);患者组中HLA-B*40等位基冈的基因频率(11%)显著低于健康对照组(19%),两者之问差异具有统计学意义(X2=6.095,P<0.01,RR值为0.47).结论 研究提示在遵义地区汉族人群中,初步认为HLA-A*31、B*58基因与HFRS呈正相关,HLA-B*40基因与HFRS呈负相关.     

山东地区汉族人群中HLA-A、-B、-DRB1等位基因与原因不明卵巢早衰相关性研究

目的探讨HLA-A,-B和-DRB1位点等位基因多态性与原因不明卵巢早衰(premature ovarian failure,POF)的相关性。方法利用毛细管电泳测序技术(Capillary Electrophoresis),对36例汉族原因不明POF患者进行HLA-A,-B,-DRB1基因分型,并以865例山东健康汉族个体造血干细胞分型资料作为对照,分析HLA等位基因频率在两组中的分布差异。结果 POF组中HLA-A*33、HLA-B*07、HLA-B*52和HLA-B*55等位基因频率显著高于对照组(P<0.05)。HLA-A*33的等位基因频率POF组为19.44%,而正常对照组为10.17%,RR=2.18;HLA-B*07的等位基因频率POF组为12.50%,而正常对照组为5.32%,RR=2.65;HLA-B*52的等位基因频率POF组为11.11%,而正常对照组为4.10%,RR=3.06;HLA-B*55的等位基因频率POF组为5.56%,而正常对照组为1.50%,RR=4.23。结论山东汉族人群中HLA-A*33、HLA-B*07、HLA-B*52和HLA-B*55等位基因可能是POF的易感基因。     

HLA高分辨等位基因与骨髓移植受者HCMV抗原血症研究

目的 分析HLA高分辨等位基因与骨髓移植术后HCMVpp65抗原血症的相关性.方法 选取2009年2月至2010年10月在我院行骨髓移植术患者48例;采用免疫组化方法检测患者HCMVpp65,采用直接测序分型方法（PCR-SBT）检测患者HLA-A＊1101、HLA-A＊0201、HLA-A＊2402、HLA-B＊4001、HLA-DRB1＊0901五个高分辨等位基因.结果 ①48例骨髓移植术后患者HCMV感染率100％;②HLA-A＊1101、HLA-A＊0201、HLA-A＊2402、HLA-B＊ 4001等位基因阳性率在pp65抗原血症12例低感染组和36例高感染组中比较没有统计学意义（P＞0.05）,其阳性率HLA-A＊1101为33.3％ （8/24）和20.8％ （15/72）、HLA-A＊0201为4.2％ （1/24）和13.9％ （10/72）、HLA-A＊ 2402为12.5％ （3/24）和19.4％ （14/72）、HLA-B＊ 4001 16.7％ （4/24）和12.5％ （9/72）;③HLA-DRB1＊0901等位基因阳性率在pp65抗原血症12例低感染组和36例高感染组中比较有统计学意义（P =0.048）,其阳性率为4.2％ （1/24）和19.4％ （14/72）;④HLA-DRB1＊0901组患者pp65抗原血症高于HLA-A＊2402组（P =0.007）和HLA-A＊1101组患者（P=0.028）,HLA-A＊0201组患者pp65抗原血症高于HLA-A＊2402组患者（P=0.02）,其他高分辨等位基因组之间pp65抗原血症差异没有统计学意义（P＞0.05）.结论 HLA-DRB1＊0901等位基因可能与骨髓移植术后患者发生高HCMVpp65抗原血症有关;HLA-A＊2402等位基因可能与骨髓移植术后患者发生低HCMVpp65抗原血症有关.     

祖籍湖北汉族鼻咽癌患者与HLA抗原相关的研究

目的：探讨25例鼻咽癌患者和50例正常祖籍湖北汉族居民HLA-A，HLA-B位点抗原分型。方法：采用美国NIH标准微量淋巴细胞毒技术和免疫磁珠法分离TB淋巴细胞。结果：鼻咽癌患者组的HLA-A1，HLA-B63抗原频率明显高于正常对照组(P值分别为0．0098和0．0028)。结论：HLA-A1可能是湖北或华中地区鼻咽癌患者相关的一种区域性抗原，而HLA-B63可能是一个新的鼻咽癌相关的抗原。     

汉族HLA-A等位基因与银屑病患者相关性研究

目的 探讨HLA-A等位基因与汉族人银屑病遗传易感性。方法 利用聚合酶链反应-序列特异性引物（PCR-SSP）法，对200例银屑病患者和204例健康人的HLA-A等位基因进行检测。结果 HLA-A*2601-05等位基因与汉族人银屑病呈正相关性（20.25%vs12.25%,RR=1.65,X^2=11.76,P=0.0006,Pc=0.0066),HLA-A*0201-17等位基因与汉族人银屑病呈负相关（4.25%vs9.80%,RR=0.43,X^2=10.26,P=0.0013,Pc=0.0143),HLA-A*2601-05等位基因仅与有家族史银屑病呈正相关（RR=2.04,X^2=12.49,P=0.0004,Pc=0.0044),HLA-A*2601-05等位基因与I型银屑病呈正相关（RR=1.68,X^2=11.67,P=0.0006,Pc=0.0066)。结论 HLA-A*2601-05可能是银屑病的易感基因或与易感基因相连锁。HLA-A*2601-05仅为有家族史银屑病和I型银屑病的危险基因。     

格林-巴利综合征与HLA-A、-B基因关联的研究

目的研究急性运动性轴索型神经病(AMAN)的易感性与HLA-A、-B等位基因分型的关系,探讨AMAN患者免疫遗传的特点. 方法用改良快速盐析法自研究对象静脉血中抽提基因组DNA,采用聚合酶链反应-顺序特异性引物法(PCR-SSP)对33例AMAN患者和132例健康人进行HLA-A、-B位点等位基因分型. 结果发现AMAN组HLA-B15、-B35频率升高,RR(relative risk)值分别为4.09和7.08.Pc分别为0.015和0.0008. 结论 HLA-B15、-B35与AMAN的易感性可能有关联.     

麻风病与HLA-A、HLA-B、HLA-DRB1、HLA-DQ等位基因关联性分析

目的 探讨中国山东人群HLA-A、HLA-B、HLA-DRB1、HLA-DQ等位基因与麻风病的相关性.方法 采用序列特异性引物聚合酶链反应法(PCR-SSP)对40例麻风病患者及20例健康对照者进行HLA-A、B、DRB1、DQ等位基因分型,x2检验基因频率差异.结果 麻风病患者HLA-B*13(x2=7.067,P=0.008)、DQ*02(x2 =4.156,P=0.041)基因频率较健康对照组低,有统计学意义(P＜0.05).LL型麻风患者HLA-B* 13(x2=7.159,P=0.007)等位基因频率降低、HLA-DRB1*15(x2=4.073,P=0.044)等位基因频率升高,与健康对照组相比均具有统计学意义(P＜0.05).TT型麻风病患者HLA-B *40(P =0.037)、DQ *05(x2 =5.147,P=0.023)等位基因频率高于健康对照组,差异具有统计学意义(P＜0.05).结论 HLA-B * 13、DQ*02基因可能对麻风病易感性有拮抗作用,可能是保护基因;HLA-B* 13可能是LL型拮抗基因、DRB1*15可能是LL型的易感基因;HLA-B* 40、DQ *05可能是TT型的易感基因.     

上海地区汉族白塞病与HLA-B*51关联研究

为探讨白塞病的发病机制与HLAI类基因之间的关系,我们采用聚合酶链反应/顺序特异的寡核苷酸探针(PCR-SSO)反向杂交方法,对上海地区汉族69例白塞病患者及296例正常对照进行HLA-A、B基因的检测。结果显示白塞病患者组中HLA-B*51基因检出频率(34.8%)显著高于正常对照组(12.8%),X2和RR值分别为19.11和3.62(P<0.0001,Pc<0.005)。完全型白塞病患者组HLA-B51基因频率(52.4%)更是远远高于对照组,X2和RR值分别为39.4和7.5,(P<0.00001,Pc<0.001)。此外,HLA-B*46基因检出频率(26.1%)较对照组(11.1%)高,Pc<0.05。推测上海地区汉族白塞病的发病与HLA-B*51基因相关;患者组中HLA-B*46频率升高,可能与HLA-B*51一起参与白塞病的发病或因与患者组中某些HLA单倍型组合之间存在连锁不平衡有关。     

Association of human leukocyte antigens with nasopharyngeal carcinoma in high-risk multiplex families in Taiwan

An association between specific human leukocyte antigens (HLA) alleles and nasopharyngeal carcinoma (NPC) has been reported for sporadic NPC, but studies of familial NPC are lacking. We evaluated this association with familial NPC in a study of 301 NPC cases and 1010 family and community controls from Taiwan. Class I HLA alleles were characterized using a sequence-based typing protocol. Allele frequencies between case and control groups were compared by χ² or exact tests. For alleles associated with NPC, odds ratios (OR) and 95% confidence intervals (CI) were calculated. Similar allelic frequency distribution and HLA associations were found as those previously reported for sporadic NPC: protective effect for HLA-A*1101 and increased risk for HLA-A*0207, HLA-A*3303, HLA-B*3802, and HLA-B*5801. Overall, the magnitude of observed associations was weakest when cases were compared with sibling controls and strongest when compared with unrelated community controls. Evaluating the joint effect of HLA-A*0207 and HLA-B*4601, individuals who were carriers of HLA-A*0207 with or without the presence of HLA-B*4601 had a 1.9-fold (95% CI = 1.0–3.4) and 2.1-fold (95% CI = 0.83–5.3) risk of NPC, respectively. Conversely, carriers of HLA-B*4601 in the absence of HLA-A*0207 had a 50% reduction in NPC risk (95% CI = 0.27–0.93). Comparable findings from our family study and those from previous sporadic studies were found with the notable exception of a lack of positive association between HLA-B*4601 and familial NPC in the absence of HLA-A*0207. This finding requires replication in larger studies.     

Association of HLA class I and leukemia in mestizo patients of the state of Zulia, Venezuela

The Human Leukocyte Allele (HLA) Class I (A, B, C) and Acute Lymphoid Leukemia and Myeloid Leukemia association, was determined by polymerase chain reaction--sequence specific primers (PCR-SSP) in 60 patients and 30 healthy controls. The results were reported as allelic frequencies and haplotype. The Chi-square corrected, Fisher's Test, Relative risk and etiologic fraction were calculated. A significant positive association was showed between HLA-B*39 (RR = 16.184; p = 0.0237) and HLA C*03 (RR = 5.0; p = 0.0127) alleles and Mycloid Leukaemia. Positive associations between haplotypes 2 loci: HLA-A*02-C*03 (RR = 6.0; p = 0.0153), A*24-C*03 (RR = 16.184; p = 0.0237), B*40-C*03 (RR = 10.706; p = 0.0021) and haplotype 3 loci: HLA-A*02-B*40-C*03 (RR = 8.11; p = 0.0102) and Myeloid Leukemia were found. No association was evident in Acute Lymphoid Leukemia. No negative association with Leukemias were observed.     

Protective and susceptible HLA polymorphisms in IgA nephropathy patients with end-stage renal failure

Idiopathic immunoglobulin A (IgA) nephropathy is characterised by an extreme variability in clinical course, leading to end-stage renal failure in 15-20% of adults. This subgroup of patients with IgA nephropathy is usually included in the waiting lists of organ exchange organisations. The frequency of HLA-A,B,DR antigens of this subset of IgA nephropathy patients was calculated and compared to controls. The antigens HLA-B35 and DR5 were significantly increased in the patients with relative risk values of 1.385 and 1.487, respectively. The antigens HLA-B7, B8, DR2, and DR3 were found in a significantly lower frequency in the patients as compared to the controls. The relative risk (RR) values ranged between 0.695 and 0.727. Consequently, the haplotypes HLA-A1, B8, DR3, HLA-A3, B7, DR2, HLA-A2, B7, DR2 together with HLA-A1, B15, DR4, HLA-A9, B12, DR7, and HLA-A10, B18, DR2 were found to be protective with RR values ranging from 0.309 to 0.587. The only susceptible haplotype observed was HLA-A2-B5, DR5 (RR=2.990).     

Study on the association of HLA with malignant lymphoma

The association of HLA with malignant lymphomas in 50 Chinese patients of the HAN nationality was investigated. The frequencies of antigens HLA-A and -C and the majority of HLA-B phenotypes were not significantly different between the patient and control groups, whereas the antigen frequency of HLA-B16 was increased significantly (P less than 0.025) in the patient group. The relative risk associated with HLA-B16 was 2.5694. The association of this antigen with malignant lymphoma might be unique for Oriental patients.     

Association of human leucocyte antigen Class I (HLA-A and HLA-B) with chronic hepatitis C virus infection in Egyptian patients

Egypt has the highest prevalence of hepatitis C virus (HCV) in the world, ranging from 6% to 28% with an average of approximately 13.8% in the general population. It has been reported that human leucocyte antigen (HLA) alleles are associated with the outcome of HCV infection, but this associations showed ethnic and geographical differences. The objective of this study is to investigate the association between the frequencies of HLA Class I and chronic HCV infection in Egyptian patients and to find out whether there is a relation between certain HLA Class I antigens and HCV viral load, degree of fibrosis, activity and alanine aminotransferase (ALT) level. A case control study was conducted on 100 patients with chronic HCV infection and 150 healthy controls. HLA-A and HLA-B typing by complement-dependent micro-lympho-cytotoxicity assay was performed for both groups. HLA-A11 antigen was significantly increased in patients with chronic HCV infection versus controls (OR 3.98; 95% CI = 1.85-8.89; P = 0.001; and Pc = 0.021). HLA-B12, HLA-B13, HLA-B17 and HLA-B40 were higher in patients, and HLA-A32 and HLA-B14 were higher in controls, although the significance was lost after correction for multiple testing. HLA-A9 was significantly associated with low viral load (P = 0.008, Pc = 0.048). The results of this work implicate that HLA-A11 antigen may influence chronic HCV infection and may play a role in viral persistence. Different HLA Class I antigens are not associated with degree of liver fibrosis, grades of activity or level of ALT. However, HLA-A9 is associated with low HCV viral load in chronic HCV Egyptian patients.     

HLA determinants in 70 Danish patients with idiopathic haemochromatosis

HLA-A, -B, -C and -DR antigens were determined in 70 unrelated Danish patients with idiopathic haemochromatosis. The frequencies of HLA-A and -B antigens compared to 1967 normal control subjects and the relative risk values (RR) were: A3, 80.0% vs. 26.9% (P less than 0.0001), RR = 10.9; B7, 60.0% vs. 26.8% (P less than 0.0001), RR = 4.1; B14, 10.0% vs. 4.5% (P = 0.03), RR = 2.4; B47, 4.3% vs. 0.5% (P less than 0.0001), RR = 9.7; A3, B7, 51.4% vs. 12.2% (P less than 0.0001), RR = 7.6; A3, B14, 10.0% vs. 1.4% (P less than 0.0001), RR = 7.7; A3, B47, 4.3% vs. 0.5% (P less than 0.0001), RR = 9.7. Six patients (8.6%) possessed none of these four typical antigens. There was no association between disease and the frequencies of HLA-C and HLA-DR antigens. The pattern of HLA-antigens associated with haemochromatosis in Denmark shows similarities to those reported both in Germany, being HLA-A3, B7 dominated, and in Brittany, Great Britain and Central Sweden, being HLA-A3, B14 dominated.     

HLA-A、B、DRB1等位基因多态性与中国南方鼻咽癌的相关性研究

目的：探讨南方人群中鼻咽癌（NPC）易感性与HLA多态性之间的关联。方法：应用聚合酶链反应／序列特异性引物（PCR-SSP）方法对35例NPC患者及60例正常对照进行HLA-A、HLA-B及DRBI基因分型。结果：NPC患者的HLA-A＊02、HLA-B＊58及HLA-DRBI＊03基因位点的频率高于正常对照组，HLA-B＊40基因位点的频率低于正常对照组。结论：HLA-A＊02、HLA—B＊58及HLA—DRB1＊03可能是NPC的易感性基因，HLA-B＊40可能是NPC的保护性基因。